<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00526318</url>
  </required_header>
  <id_info>
    <org_study_id>GPOH-NB2004-HR</org_study_id>
    <secondary_id>CDR0000564820</secondary_id>
    <secondary_id>UNI-KOELN-161</secondary_id>
    <secondary_id>EU-20661</secondary_id>
    <nct_id>NCT00526318</nct_id>
  </id_info>
  <brief_title>Combination Chemotherapy Followed by Stem Cell Transplant and Isotretinoin in Treating Young Patients With High-Risk Neuroblastoma</brief_title>
  <official_title>Trial Protocol for the Treatment of Children With High Risk Neuroblastoma (NB2004-HR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Giving chemotherapy before an autologous stem cell transplant stops the growth of
      tumor cells by stopping them from dividing or by killing them. It also prepares the patient's
      bone marrow for the stem cell transplant. The stem cells are given to the patient to replace
      the blood-forming cells that were destroyed by the chemotherapy. Giving isotretinoin after
      transplant may kill any remaining tumor cells. It is not yet known which combination
      chemotherapy regimen is more effective when given before a stem cell transplant and
      isotretinoin in treating neuroblastoma.

      PURPOSE: This randomized clinical trial is studying two different combination chemotherapy
      regimens to compare how well they work when given before a stem cell transplant and
      isotretinoin in treating young patients with high-risk neuroblastoma.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  Compare the event-free survival of pediatric patients with high-risk neuroblastoma
           treated with standard induction chemotherapy vs topotecan hydrochloride-containing
           induction chemotherapy followed by myeloablative autologous stem cell transplantation
           and consolidation therapy with isotretinoin.

      Secondary

        -  Compare the overall survival of patients treated with these regimens.

        -  Compare early response (complete response, very good partial response, partial response,
           mixed response, stable disease, and progression/relapse) after 2 courses of standard vs
           experimental induction chemotherapy (or after 60 days if the second course is not yet
           finished).

        -  Compare response to standard vs experimental induction chemotherapy before autologous
           stem cell transplantation (or after 280 days if induction chemotherapy is not yet
           finished).

        -  Compare the toxicity of standard vs experimental induction chemotherapy during courses 1
           and 2 and the frequency of ≥ grade 3 toxicity during the last 6 courses of induction
           chemotherapy.

        -  Compare the extent of initial surgery and best surgery (biopsy vs incomplete resection
           vs macroscopic complete resection) and the frequency of complications related to surgery
           (e.g., nephrectomy, bleeding, infection, or intestinal obstruction).

        -  Compare the acute and long-term side effects of external-beam radiotherapy.

        -  Correlate the activity of MIBG and whole-body radiation dose.

        -  Collect and store tumor material in the tumor bank for future evaluation of other
           molecular markers (MYCN and status of chromosome 1p and 11q) and prognostic significant
           gene signatures.

      OUTLINE: This is a multicenter study. Patients are stratified according to disease stage,
      lactate dehydrogenase (LDH) status, MYCN status, and age at diagnosis (stage 4 disease; LDH
      not elevated; any MYCN status; age at diagnosis 1-21 years vs stage 4 disease; LDH elevated;
      any MYCN status; age at diagnosis ≥ 1 but &lt; 2 years vs stage 4 disease; LDH elevated; any
      MYCN status; age at diagnosis 2-21 years vs localized disease; MYCN amplification; age at
      diagnosis ≥ 6 months)

        -  Induction chemotherapy: Patients are randomized to 1 of 2 induction chemotherapy arms.

             -  Arm I (standard): Patients receive N5 chemotherapy comprising cisplatin IV
                continuously over 96 hours and etoposide phosphate IV continuously over 96 hours on
                days 1-4 and vindesine IV over 1 hour on day 1. Patients also receive filgrastim
                (G-CSF) subcutaneously (SC) once daily beginning on day 9 and continuing until
                blood counts recover. Patients then receive N6 chemotherapy comprising vincristine
                IV over 1 hour on days 1 and 8, dacarbazine IV over 1 hour on days 1-5, ifosfamide
                IV continuously over 120 hours on days 1-5, and doxorubicin hydrochloride IV over 4
                hours on days 6 and 7. Patients also receive G-CSF SC once daily beginning on day
                10 and continuing until blood counts recover. Treatment with N5 and N6 chemotherapy
                alternates every 21 days for 6 courses (N5 chemotherapy is given in courses 1, 3,
                and 5 and N6 chemotherapy is given in courses 2, 4, and 6).

             -  Arm II (experimental): Patients receive N8 chemotherapy comprising cyclophosphamide
                IV over 1 hour on days 1-7, topotecan hydrochloride IV continuously over 168 hours
                on days 1-7, and etoposide phosphate IV over 1 hour on days 8-10. Patients also
                receive G-CSF SC once daily beginning on day 12 and continuing until blood counts
                recover. Treatment with N8 chemotherapy repeats every 21 days for 2 courses.
                Patients then receive N5 chemotherapy alternating with N6 chemotherapy as in arm I.

        -  Surgery: Patients may undergo secondary surgery after completion of 4 or 6 courses of
           induction chemotherapy but prior to radiotherapy.

        -  Radiotherapy (131I-MIBG therapy and external-beam radiotherapy [EBRT]): Patients with
           active residual primary tumor after the completion of induction chemotherapy undergo
           ^131I-MIBG therapy* prior to autologous stem cell transplantation (ASCT) and EBRT after
           ASCT.

      NOTE: *Patients with MIBG negative neuroblastoma at initial diagnosis will only receive EBRT.

        -  Myeloablative ASCT: Patients receive melphalan IV over 30 minutes on days -8 to -5,
           etoposide phosphate IV over 4 hours on day -4, and carboplatin IV over 1 hour on days -4
           to -2. Patients undergo reinfusion of CD34+ stem cells on day 0. Patients also receive
           G-CSF SC or IV over 4 hours once daily beginning on day 2 and continuing until blood
           counts recover.

        -  Consolidation therapy (isotretinoin)*: Beginning 30 days after ASCT, patients receive
           oral isotretinoin once daily on days 1-14. Treatment repeats every 28 days for up to 6
           courses. Beginning 3 months later, patients receive an additional 3 courses of
           isotretinoin.

      NOTE: *Isotretinoin must not be given concurrently with radiotherapy

      After completion of study treatment, patients are followed every 6 weeks for 1 year, every 3
      months for 4 years, and then every 6 months thereafter.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2007</start_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <primary_purpose>Treatment</primary_purpose>
  </study_design_info>
  <primary_outcome>
    <measure>Event-free survival (EFS)</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall survival (OS)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of well established clinical and molecular risk factors on EFS and OS</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Early response, measured after 2 courses of induction chemotherapy</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Response to induction therapy, measured before autologous stem cell transplantation</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Toxicity during the first 2 courses and the last 6 courses of induction chemotherapy</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of the extent of initial and best surgery on outcome and frequency of complications</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute and late toxicity of radiotherapy</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Correlation of MIBG activity with whole-body radiation dose</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Molecular markers (MYCN and status of chromosome 1p and 11q)</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">360</enrollment>
  <condition>Neuroblastoma</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>filgrastim</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>carboplatin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cisplatin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>cyclophosphamide</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dacarbazine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>doxorubicin hydrochloride</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>etoposide phosphate</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ifosfamide</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>isotretinoin</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>melphalan</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>topotecan hydrochloride</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vincristine sulfate</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>vindesine</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>autologous hematopoietic stem cell transplantation</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>iobenguane I 131</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiation therapy</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Diagnosis of neuroblastoma according to any of the following criteria:

               -  Histological diagnosis from tumor tissue

               -  Presence of distinct neuroblastoma cells in the bone marrow and elevated
                  catecholamine metabolites (HVA, VMA) in blood or urine

          -  High-risk disease, meeting 1 of the following criteria:

               -  Stage 4 disease, regardless of the MYCN status (1-21 years of age)

               -  Stage 1-3 or 4S disease with MYCN amplification (6 months -21 years of age)

        PATIENT CHARACTERISTICS:

          -  Not pregnant or nursing

          -  Fertile patients must use effective contraception (hormonal contraception or
             intra-uterine device [IUD])

        PRIOR CONCURRENT THERAPY:

          -  No concurrent participation in another clinical trial that would preclude the
             interventions or outcome assessment of this clinical trial

          -  No other concurrent anticancer therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frank Berthold, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Children's Hospital Medical Center, Cincinnati</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kinderklinik - Universitaetsklinikum Aachen</name>
      <address>
        <city>Aachen</city>
        <zip>D-52074</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. Mertens, MD, PhD</last_name>
      <phone>49-241-808-9902</phone>
      <email>rmertens@ukaachen.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Augsburg</name>
      <address>
        <city>Augsburg</city>
        <zip>DOH-86156</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Astrid Gnekow</last_name>
      <phone>49-821-400-3603</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Bayreuth</name>
      <address>
        <city>Bayreuth</city>
        <zip>D-95445</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>T. Rupprecht</last_name>
      <phone>49-921-400-1400</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lothar Schweigerer, MD</last_name>
      <phone>49-30-9401-2345</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Charite University Hospital - Campus Virchow Klinikum</name>
      <address>
        <city>Berlin</city>
        <zip>D-13353</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gunter Henze</last_name>
      <phone>49-30-450-660-31</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhauus Bielfeld</name>
      <address>
        <city>Biefeld</city>
        <zip>33617</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>N. Jorch, MD</last_name>
      <phone>49-52-177-278-050</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kinderklinik der Universitaet Bonn</name>
      <address>
        <city>Bonn</city>
        <zip>D-53113</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Udo Bode, MD</last_name>
      <phone>49-228-2873-3215</phone>
      <email>udo.bode@ukb.uni-bonn.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Staedtisches Klinikum - Howedestrase</name>
      <address>
        <city>Braunschweig</city>
        <zip>38118</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Eberl, MD</last_name>
      <phone>49-531-595-1222</phone>
      <email>w.eberl@kliniklum-braunschweig.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Bremen-Mitte</name>
      <address>
        <city>Bremen</city>
        <zip>D-28205</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arnulf Pekrun, MD, PhD</last_name>
      <phone>49-421-497-3656</phone>
      <email>arnulf.pekrun@klinikum-bremen-mitte.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Chemnitz gGmbH</name>
      <address>
        <city>Chemnitz</city>
        <zip>D-09116</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Krause, MD</last_name>
      <phone>49-371-3332-4124</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Coburg</name>
      <address>
        <city>Coburg</city>
        <zip>96450</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roland Frank, MD</last_name>
      <phone>49-9561-22-5547</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children's Hospital</name>
      <address>
        <city>Cologne</city>
        <zip>D-50924</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frank Berthold, MD</last_name>
      <phone>49-221-478-4380</phone>
      <email>frank.berthold@uk-koeln.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Carl - Thiem - Klinkum Cottbus</name>
      <address>
        <city>Cottbus</city>
        <zip>D-03048</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>D Mobius, MD</last_name>
      <phone>49-355-462336</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Vestische Kinderklinik</name>
      <address>
        <city>Datteln</city>
        <zip>45704</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W. Andler, MD</last_name>
      <phone>49-023-63-9750</phone>
      <email>w.andler@kinderklinik-datteln.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Lippe - Detmold</name>
      <address>
        <city>Detmold</city>
        <zip>D-32756</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus Wesseler, MD</last_name>
      <phone>49-523-172-4511</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Dortmund</name>
      <address>
        <city>Dortmund</city>
        <zip>D-44137</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dominik T. Schneider, MD</last_name>
      <phone>49-231-953-2-1670</phone>
      <email>dominik.schneider@klinikumdo.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Carl Gustav Carus</name>
      <address>
        <city>Dresden</city>
        <zip>D-01307</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Suttorp, MD</last_name>
      <phone>49-351-458-0</phone>
      <email>meinolf.suttorp@uniklinikum-dresden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Duesseldorf</name>
      <address>
        <city>Duesseldorf</city>
        <zip>D-40225</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arndt Borkhardt</last_name>
      <phone>49-211-311-7990</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Duisburg</name>
      <address>
        <city>Duisburg</city>
        <zip>D-47055</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruef, MD</last_name>
      <phone>49-203-733-2421</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Erfurt</name>
      <address>
        <city>Erfurt</city>
        <zip>99089</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel Sauerbrey, MD</last_name>
      <phone>49-361-781-3729</phone>
      <email>asauerbrey@erfurt.helios-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaets - Kinderklinik</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W. Holter, MD</last_name>
      <phone>49-9131-853-3118</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Essen</name>
      <address>
        <city>Essen</city>
        <zip>D-45147</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Kremens, MD</last_name>
      <phone>49-201-723-2453</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum der J.W. Goethe Universitaet</name>
      <address>
        <city>Frankfurt</city>
        <zip>D-60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Klingebiel, MD</last_name>
      <phone>49-69-6301-5094</phone>
      <email>thomas.klingebiel@kgu.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetskinderklinik - Universitaetsklinikum Freiburg</name>
      <address>
        <city>Freiburg</city>
        <zip>D-79106</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte Niemeyer, MD</last_name>
      <phone>49-761-270-4506</phone>
      <email>charlotte.niemeyer@uniklinik-freiburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kinderklinik</name>
      <address>
        <city>Giessen</city>
        <zip>D-35385</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alfred Reiter, MD</last_name>
      <phone>49-641-994-3420</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Goettingen</name>
      <address>
        <city>Goettingen</city>
        <zip>D-37075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Lakomek, MD</last_name>
      <phone>49-551-398-600</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitats - Kinderklinik</name>
      <address>
        <city>Greiswald</city>
        <zip>17487</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>James F. Beck, MD</last_name>
      <phone>49-383-486-6325</phone>
      <email>beck@uni-greifswald.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Halle</name>
      <address>
        <city>Halle</city>
        <zip>D-06097</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dieter Koerholz, MD</last_name>
      <phone>49-345-557-2387</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenhaus St. Elisabeth und St. Barbara</name>
      <address>
        <city>Halle</city>
        <zip>D-06110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>G. Guenther, MD</last_name>
      <phone>49-345-482-50</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Hamburg - Eppendorf</name>
      <address>
        <city>Hamburg</city>
        <zip>D-20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rudolf Erttmann, MD</last_name>
      <phone>49-40-4717-4270</phone>
      <email>erttmann@uke.uni-hamburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>D-30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Welte, MD</last_name>
      <phone>49-511-532-6710</phone>
      <email>welte.karl.h@mh-hannover.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaets-Kinderklinik Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>D-69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas E. Kulozik, MD, PhD</last_name>
      <phone>49-6221-564-555</phone>
      <email>andreas.kulozik@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Gemeinschaftskrankenhaus</name>
      <address>
        <city>Herdecke</city>
        <zip>58313</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christoph Tautz, MD</last_name>
      <phone>49-2330-62-3914</phone>
      <email>ctautz@yahoo.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum des Saarlandes</name>
      <address>
        <city>Homburg</city>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Norbert Graf</last_name>
      <phone>49-6841-162-4000</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaets - Kinderklinik</name>
      <address>
        <city>Jena</city>
        <zip>D-07745</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Zintl, MD</last_name>
      <phone>49-3641-938-270</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Staedtisches Klinikum Karlsruhe gGmbH</name>
      <address>
        <city>Karlsruhe</city>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A. Leipold</last_name>
      <phone>49-721-974-3311</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Kassel</name>
      <address>
        <city>Kassel</city>
        <zip>D-34125</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martina Rodehueser, MD</last_name>
      <phone>49-561-980-3066</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Schleswig-Holstein - Kiel Campus</name>
      <address>
        <city>Kiel</city>
        <zip>D-24105</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>A. Claviez, MD</last_name>
      <phone>49-431-597-1622</phone>
      <email>a.claviez@pediatrics.uni-kiel.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Kemperhof Koblenz</name>
      <address>
        <city>Koblenz</city>
        <zip>D-56065</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Rister, MD</last_name>
      <phone>49-261-499-2602</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Krefeld GmbH</name>
      <address>
        <city>Krefeld</city>
        <zip>D-47805</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>S. Volpel, MD</last_name>
      <phone>49-2151-32-2375</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>St. Annastift Krankenhaus</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67065</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Barbara Selle, MD</last_name>
      <phone>49-621-5702-4449</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaets - Kinderklinik - Luebeck</name>
      <address>
        <city>Luebeck</city>
        <zip>D-23538</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter P. Bucsky, MD</last_name>
      <phone>49-451-500-2956</phone>
      <email>bucsky@paedia.ukl.mu-luebeck.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg</name>
      <address>
        <city>Magdeburg</city>
        <zip>D-39120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P. Vorwerk, MD</last_name>
      <phone>49-394-672-791</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johannes Gutenberg University</name>
      <address>
        <city>Mainz</city>
        <zip>D-55101</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P. Gutjahr, MD</last_name>
      <phone>49-6131-17-2112</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Staedtisches Klinik - Kinderklinik</name>
      <address>
        <city>Mannheim</city>
        <zip>D-68167</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>M. Duerken</last_name>
      <phone>49-621-383-2243</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Giessen und Marburg GmbH - Marburg</name>
      <address>
        <city>Marburg</city>
        <zip>D-35043</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H. Christiansen, MD</last_name>
      <phone>49-6421-286-2671</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Minden</name>
      <address>
        <city>Minden</city>
        <zip>D-32423</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bernhard Erdlenbruch, MD</last_name>
      <phone>49-57-1801-4601</phone>
      <email>bernhard.erdlenbruch@klinikum-minden.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinik und Poliklinik fuer Kinder und Jugendmedizin - Universitaetsklinikum Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>D-48149</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heribert F. Juergens, MD</last_name>
      <phone>49-251-834-7742</phone>
      <email>jurgh@uni-muenster.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Muenchen Schwabing</name>
      <address>
        <city>Munich</city>
        <zip>80804</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Burdach, MD, PhD</last_name>
      <phone>49-89-3068-2352</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dr. von Haunersches Kinderspital der Universitaet Muenchen</name>
      <address>
        <city>Munich</city>
        <zip>D-80337</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Irene Schmid, MD</last_name>
      <phone>49-89-5160-7978</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Neubrandenburg</name>
      <address>
        <city>Neubrandenburg</city>
        <zip>17036</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>H. J. Feickert, MD, PhD</last_name>
      <phone>49-395-775-2901</phone>
      <email>feickerthj@dbk-nb.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Cnopf'sche Kinderklinik</name>
      <address>
        <city>Nuremberg</city>
        <zip>90419</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>W. Scheurlen</last_name>
      <phone>49-911-334-002</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinikum Oldenburg</name>
      <address>
        <city>Oldenburg</city>
        <zip>26133</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hermann Mueller, MD</last_name>
      <phone>49-441-403-2013</phone>
      <email>mueller.hermann@klinikum-oldenburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Klinik St. Hedwig-Kinderklinik</name>
      <address>
        <city>Regensburg</city>
        <zip>93049</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ove Peters</last_name>
      <phone>49-941-369-5404</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kinderklinik - Universitaetsklinikum Rostock</name>
      <address>
        <city>Rostock</city>
        <zip>D-18057</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carl Friedrich Classen, MD, PD</last_name>
      <phone>49-381-494-0</phone>
      <email>carl-friedrich.classen@med.uni-rostock.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kinderklink Siegen Deutsches Rotes Kreuz</name>
      <address>
        <city>Siegen</city>
        <zip>D-57072</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rainer Burghard, MD</last_name>
      <phone>49-271-2345-0</phone>
      <email>rainer.burghard@drk-kinderklinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Johanniter-Kinderklinik</name>
      <address>
        <city>St. Augustin</city>
        <zip>53757</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roswitha Dickerhoff, MD</last_name>
      <phone>49-22-41-2491</phone>
      <email>roswitha.dickerhoft@uni-bonn.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Olgahospital</name>
      <address>
        <city>Stuttgart</city>
        <zip>D-70176</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Bielack, MD</last_name>
      <phone>49-711-99-24-61</phone>
      <email>st.bielack@olgahospital.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Krankenanstalt Mutterhaus der Borromaerinnen</name>
      <address>
        <city>Trier</city>
        <zip>D-54290</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wolfgang Rauh, MD</last_name>
      <phone>49-651-947-2654</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaetsklinikum Tuebingen</name>
      <address>
        <city>Tuebingen</city>
        <zip>D-72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rupert Handgretinger, MD</last_name>
      <phone>49-7071-298-2087</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm</name>
      <address>
        <city>Ulm</city>
        <zip>D-89075</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Klaus M. Debatin, MD</last_name>
      <phone>49-731-5002-7790</phone>
      <email>klaus-michael.debatin@medizin.uni-ulm.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaets - Kinderklinik Wuerzburg</name>
      <address>
        <city>Wuerzburg</city>
        <zip>D-97080</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>P. G. Schlegel, MD</last_name>
      <phone>49-931-201-27-831</phone>
      <email>schlegel@mail.uni-wuerzburg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Helios Kliniken Wuppertal University Hospital</name>
      <address>
        <city>Wuppertal</city>
        <zip>D-42283</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>K. Sinha, MD</last_name>
      <phone>49-202-896-2441</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Aarau</name>
      <address>
        <city>Aarau</city>
        <zip>CH-5001</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>R. Angst</last_name>
      <phone>41-62-838-4906</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Universitaets-Kinderspital beider Basel</name>
      <address>
        <city>Basel</city>
        <zip>CH-4005</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Kuhne, MD</last_name>
      <phone>41-61-685-6565</phone>
      <email>thomas.kuehne@ukbb.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kinderspital Luzern</name>
      <address>
        <city>Lucerne 16</city>
        <zip>CH-6000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>U. Caflisch, MD</last_name>
      <phone>41-41-205-11-11</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Ostschweizer Kinderspital</name>
      <address>
        <city>St. Gallen</city>
        <zip>CH-9006</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeanette Greiner, MD</last_name>
      <phone>41-71-243-13-60</phone>
      <email>jeanette.greiner@kispisg.ch</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Children's Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>CH-8032</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felix Niggli, MD</last_name>
      <phone>41-44-266-7823</phone>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 5, 2007</study_first_submitted>
  <study_first_submitted_qc>September 7, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 10, 2007</study_first_posted>
  <last_update_submitted>July 15, 2015</last_update_submitted>
  <last_update_submitted_qc>July 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 16, 2015</last_update_posted>
  <keyword>localized resectable neuroblastoma</keyword>
  <keyword>localized unresectable neuroblastoma</keyword>
  <keyword>regional neuroblastoma</keyword>
  <keyword>stage 4S neuroblastoma</keyword>
  <keyword>disseminated neuroblastoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neuroblastoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclophosphamide</mesh_term>
    <mesh_term>Melphalan</mesh_term>
    <mesh_term>Ifosfamide</mesh_term>
    <mesh_term>Liposomal doxorubicin</mesh_term>
    <mesh_term>Etoposide phosphate</mesh_term>
    <mesh_term>Carboplatin</mesh_term>
    <mesh_term>Doxorubicin</mesh_term>
    <mesh_term>Etoposide</mesh_term>
    <mesh_term>Vincristine</mesh_term>
    <mesh_term>Topotecan</mesh_term>
    <mesh_term>3-Iodobenzylguanidine</mesh_term>
    <mesh_term>Vindesine</mesh_term>
    <mesh_term>Isotretinoin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

